Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population
Schweizer, A, Dejager, S, Foley, J.E, Couturier, A, Ligueros-Saylan, M, Kothny, W
Published in Diabetes, obesity & metabolism (01.06.2010)
Published in Diabetes, obesity & metabolism (01.06.2010)
Get full text
Journal Article
assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
Ligueros-Saylan, M, Foley, J.E, Schweizer, A, Couturier, A, Kothny, W
Published in Diabetes, obesity & metabolism (01.06.2010)
Published in Diabetes, obesity & metabolism (01.06.2010)
Get full text
Journal Article
Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes
Mari, A, Sallas, W. M, He, Y. L, Watson, C, Ligueros-Saylan, M, Dunning, B. E, Deacon, C. F, Holst, J. J, Foley, J. E
Published in The journal of clinical endocrinology and metabolism (01.08.2005)
Published in The journal of clinical endocrinology and metabolism (01.08.2005)
Get full text
Journal Article
Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey
Tatar, M, Sezen, S, Senturk, A, Balp, M.M, Saylan, M, Keskinaslan, A
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3-year intercontinental schizophrenia outpatients health outcomes study
Treuer, T., Martenyi, F., Saylan, M., Dyachkova, Y.
Published in International journal of clinical practice (Esher) (01.05.2010)
Published in International journal of clinical practice (Esher) (01.05.2010)
Get full text
Journal Article
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
HE, Y.-L, SABO, R, CAMPESTRINI, J, WANG, Y, LIGUEROS-SAYLAN, M, LASSETER, K. C, DILZER, S. C, HOWARD, D, DOLE, W. P
Published in European journal of clinical pharmacology (01.07.2007)
Published in European journal of clinical pharmacology (01.07.2007)
Get full text
Journal Article
Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers
He, Y-L, Zhang, Y, Serra, D, Wang, Y, Ligueros-Saylan, M, Dole, W P
Published in Current medical research and opinion (01.07.2011)
Published in Current medical research and opinion (01.07.2011)
Get more information
Journal Article
Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey
Safak, Yilmaz E, Kockaya, G, Yenilmez, F.B, Saylan, M, Tatar, M, Hilal, Vural E, Vural, I.M, Akbulat, A, Gursoz, H, Artiran, G, Kerman, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Impact of Health Policy Changes on the Cost Sales of 5 Top Selling ATC1 Phramaceutical Groups in Turkey
Yenilmez, F.B, Kockaya, G, Saylan, M, Safak, Yilmaz E, Tatar, M, Hilal, Vural E, Vural, I.M, Akbulat, A, Gursoz, H, Artiran, G, Kerman, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey
Saylan, M, Safak, Yilmaz E, Yenilmez, F.B, Kockaya, G, Tatar, M, Hilal, Vural E, Vural, I.M, Akbulat, A, Gursoz, H, Artiran, G, Kerman, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey
Kockaya, G, Yenilmez, F.B, Saylan, M, Safak, Yilmaz E, Tatar, M, Hilal, Vural E, Vural, I.M, Akbulat, A, Gursoz, H, Artiran, G, Kerman, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey
Hilal, Vural E, Kockaya, G, Yenilmez, F.B, Saylan, M, Safak, Yilmaz E, Tatar, M, Vural, I.M, Akbulat, A, Gursoz, H, Artiran, G, Kerman, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Cost-Analysis of Chronic Idiopathic Urticaria Disease
Tatar, M, Senturk, A, Ergin, G, Tuna, E, Mat, C, Bulbul, Baskan E, Artuz, F, Gurer, M.A, Atakan, N, Inaloz, S, Sezen, S, Keskinaslan, A, Saylan, M
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Effect of vildagliptin on glucagon concentration during meals in patients with type 1 diabetes
Foley, J E, Ligueros-Saylan, M, He, Y-L, Holst, J J, Deacon, C F, Dunning, B E, Leone-Jones, A, Yu, T, Kelley, D E
Published in Hormone and metabolic research (01.10.2008)
Published in Hormone and metabolic research (01.10.2008)
Get more information
Journal Article
Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes
Serra, D, He, Y-L, Bullock, J, Riviere, G-J, Balez, S, Schwartz, S, Wang, Y, Ligueros-Saylan, M, Jarugula, V, Dole, W P
Published in International journal of clinical pharmacology and therapeutics (01.07.2008)
Published in International journal of clinical pharmacology and therapeutics (01.07.2008)
Get more information
Journal Article